Please assess the completion status of the following clinical trial:

Trial Title: Combined Vasopressin, Methylprednisolone, and Epinephrine for Inhospital Cardiac Arrest

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult in-patients with cardiac arrest requiring epinephrine according to current guidelines.~Exclusion Criteria:~* Age \< 18 years.~* Documented terminal illness (life expectancy \< 6 weeks).~* Do not resuscitate status.~* Cardiac arrest before arrival at hospital.~* Prior enrollment into the study (i.e. second or third inhospital arrest etc.).~* Corticosteroid treatment before the cardiac arrest.~* Any inaccurate documentation of CPR data such as medication, number of countershocks etc.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control Group (Type: PLACEBO_COMPARATOR): Patients with refractory cardiac arrest (as defined in methods) treated according to the latest guidelines for resuscitation and receiving placebo instead of vasopressin and corticosteroids
- Study Group (Type: EXPERIMENTAL): Patients with refractory cardiac arrest treated with combined vasopressin, epinephrine, and methylprednisolone during resuscitation. Patients receive stress-dose hydrocortisone for postresuscitation shock

Based on this trial design, predict the completion outcome and termination type (if applicable).